Targeted RNAi helps Texas Tech suppress HIV
Nov 23, 2009
Dr Premlata Shankar, from the Center of Excellence of Infectious Disease Research at Texas Tech University, will use Bioo Therapeutics' T3 technology for the targeted delivery of siRNA into T cells.
tags: Texas Tech in the News